281 related articles for article (PubMed ID: 28581832)
1. Evaluation of disintegrants functionality for orodispersible mini tablets.
Soulairol I; Chaheen M; Tarlier N; Aubert A; Bataille B; Sharkawi T
Drug Dev Ind Pharm; 2017 Nov; 43(11):1770-1779. PubMed ID: 28581832
[TBL] [Abstract][Full Text] [Related]
2. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
3. Influence of disintegrants in different substrate physical form on dimensional recovery of multi-component tablet.
Sarkar S; Ooi SM; Liew CV; Tan BX; Heng PW
Int J Pharm; 2014 Nov; 475(1-2):558-65. PubMed ID: 25218488
[TBL] [Abstract][Full Text] [Related]
4. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
Mehta S; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
[TBL] [Abstract][Full Text] [Related]
5. Evaluation about wettability, water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration.
Yang B; Wei C; Yang Y; Wang Q; Li S
Drug Dev Ind Pharm; 2018 Sep; 44(9):1417-1425. PubMed ID: 29557692
[TBL] [Abstract][Full Text] [Related]
6. Simplified formulations with high drug loads for continuous twin-screw granulation.
Meier R; Thommes M; Rasenack N; Krumme M; Moll KP; Kleinebudde P
Int J Pharm; 2015 Dec; 496(1):12-23. PubMed ID: 26024821
[TBL] [Abstract][Full Text] [Related]
7. Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.
Zaheer K; Langguth P
Drug Dev Ind Pharm; 2018 Mar; 44(3):444-451. PubMed ID: 29098885
[TBL] [Abstract][Full Text] [Related]
8. Functionality of disintegrants with different mechanisms after roll compaction.
Berkenkemper S; Keizer HL; Lindenberg M; Szepes A; Kleinebudde P
Int J Pharm; 2020 Jun; 584():119434. PubMed ID: 32439584
[TBL] [Abstract][Full Text] [Related]
9. Functional assessment of four types of disintegrants and their effect on the spironolactone release properties.
Rojas J; Guisao S; Ruge V
AAPS PharmSciTech; 2012 Dec; 13(4):1054-62. PubMed ID: 22899380
[TBL] [Abstract][Full Text] [Related]
10. Selection of lubricant type and concentration for orodispersible tablets.
Yi Zheng A; Teng Loh M; Wan Sia Heng P; Wah Chan L
Int J Pharm; 2024 May; 657():124190. PubMed ID: 38701910
[TBL] [Abstract][Full Text] [Related]
11. Dependence of Friability on Tablet Mechanical Properties and a Predictive Approach for Binary Mixtures.
Paul S; Sun CC
Pharm Res; 2017 Dec; 34(12):2901-2909. PubMed ID: 28983779
[TBL] [Abstract][Full Text] [Related]
12. A Simple and Inexpensive Image Analysis Technique to Study the Effect of Disintegrants Concentration and Diluents Type on Disintegration.
Berardi A; Bisharat L; Blaibleh A; Pavoni L; Cespi M
J Pharm Sci; 2018 Oct; 107(10):2643-2652. PubMed ID: 29935295
[TBL] [Abstract][Full Text] [Related]
13. The influence of ethanol on superdisintegrants and on tablets disintegration.
Bisharat L; AlKhatib HS; Muhaissen S; Quodbach J; Blaibleh A; Cespi M; Berardi A
Eur J Pharm Sci; 2019 Mar; 129():140-147. PubMed ID: 30630089
[TBL] [Abstract][Full Text] [Related]
14. Assessment of disintegrant efficacy with fractal dimensions from real-time MRI.
Quodbach J; Moussavi A; Tammer R; Frahm J; Kleinebudde P
Int J Pharm; 2014 Nov; 475(1-2):605-12. PubMed ID: 25234864
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of two novel co-processed excipients for direct compression of orodispersible tablets and mini-tablets.
Kokott M; Lura A; Breitkreutz J; Wiedey R
Eur J Pharm Biopharm; 2021 Nov; 168():122-130. PubMed ID: 34474110
[TBL] [Abstract][Full Text] [Related]
16. Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables.
Mostafa HF; Ibrahim MA; Sakr A
Pharm Dev Technol; 2013; 18(2):454-63. PubMed ID: 22881389
[TBL] [Abstract][Full Text] [Related]
17. Formulation and optimization of orodispersible tablets of diazepam.
Abed KK; Hussein AA; Ghareeb MM; Abdulrasool AA
AAPS PharmSciTech; 2010 Mar; 11(1):356-61. PubMed ID: 20232267
[TBL] [Abstract][Full Text] [Related]
18. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
[TBL] [Abstract][Full Text] [Related]
19. Latent structure analysis in the pharmaceutical process of tablets prepared by wet granulation.
Uehara N; Hayashi Y; Mochida H; Otoguro S; Onuki Y; Obata Y; Takayama K
Drug Dev Ind Pharm; 2016 Jan; 42(1):116-122. PubMed ID: 25997364
[TBL] [Abstract][Full Text] [Related]
20. Insights on the role of excipients and tablet matrix porosity on aspirin stability.
Veronica N; Liew CV; Heng PWS
Int J Pharm; 2020 Apr; 580():119218. PubMed ID: 32165224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
